Evidence map›Paper›PMID 36361892›Full record

ArticleInternational journal of molecular sciences2022

Hybrid Gold Nanorod-Based Nanoplatform with Chemo and Photothermal Activities for Bimodal Cancer Therapy.

Lilia Arellano-Galindo, Eva Villar-Alvarez, Alejandro Varela, Valeria Figueroa, Javier Fernandez-Vega, Adriana Cambón, Gerardo Prieto, Silvia Barbosa, Pablo Taboada

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Pharmaceutics · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lilia Arellano-GalindoGrupo de Física de Coloides y Polímeros, Departamento de Física de Partículas, Facultad de Física, Instituto de Materiales (IMATUS) e Instituto de Investigaciones Sanitarias (IDIS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
Eva Villar-AlvarezGrupo de Física de Coloides y Polímeros, Departamento de Física de Partículas, Facultad de Física, Instituto de Materiales (IMATUS) e Instituto de Investigaciones Sanitarias (IDIS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.ORCID 0000-0003-4023-1375
Alejandro VarelaGrupo de Física de Coloides y Polímeros, Departamento de Física de Partículas, Facultad de Física, Instituto de Materiales (IMATUS) e Instituto de Investigaciones Sanitarias (IDIS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
Valeria FigueroaGrupo de Física de Coloides y Polímeros, Departamento de Física de Partículas, Facultad de Física, Instituto de Materiales (IMATUS) e Instituto de Investigaciones Sanitarias (IDIS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
Javier Fernandez-VegaGrupo de Física de Coloides y Polímeros, Departamento de Física de Partículas, Facultad de Física, Instituto de Materiales (IMATUS) e Instituto de Investigaciones Sanitarias (IDIS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.ORCID 0000-0002-4658-3446
Adriana CambónGrupo de Física de Coloides y Polímeros, Departamento de Física de Partículas, Facultad de Física, Instituto de Materiales (IMATUS) e Instituto de Investigaciones Sanitarias (IDIS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
Gerardo PrietoGrupo de Biofísica e Interfases, Departamento de Física Aplicada, Facultad de Física, Instituto de Materiales (IMATUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.ORCID 0000-0002-3010-7197
Silvia BarbosaGrupo de Física de Coloides y Polímeros, Departamento de Física de Partículas, Facultad de Física, Instituto de Materiales (IMATUS) e Instituto de Investigaciones Sanitarias (IDIS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.ORCID 0000-0003-1831-1686
Pablo TaboadaGrupo de Física de Coloides y Polímeros, Departamento de Física de Partículas, Facultad de Física, Instituto de Materiales (IMATUS) e Instituto de Investigaciones Sanitarias (IDIS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.ORCID 0000-0002-2903-7857

Funding

Agencia Estatal de Investigación de España PID2019-109517RB-I00
6 · The paper itself

Abstract

Metal nanoparticles (NPs), particularly gold nanorods (AuNRs), appear as excellent platforms not only to transport and deliver bioactive cargoes but also to provide additional therapeutic responses for diseased cells and tissues and/or to complement the action of the carried molecules. In this manner, here, we optimized a previous developed metal-based nanoplatform composed of an AuNR core surrounded by a polymeric shell constructed by means of the layer-by-layer approach, and in which very large amounts of the antineoplasic drug doxorubicin (DOXO) in a single loading step and targeting capability thanks to an outer hyaluronic acid layer were incorporated by means of an optimized fabrication process (PSS/DOXO/PLL/HA-coated AuNRs). The platform retained its nanometer size with a negative surface charge and was colloidally stable in a range of physiological conditions, in which only in some of them some particle clustering was noted with no precipitation. In addition, the dual stimuli-responsiveness of the designed nanoplatform to both endogenous proteases and external applied light stimuli allows to perfectly manipulate the chemodrug release rates and profiles to achieve suitable pharmacodynamics. It was observed that the inherent active targeting abilities of the nanoplatfom allow the achievement of specific cell toxicity in tumoral cervical HeLa cells, whilst healthy ones such as 3T3-Balb fibroblast remain safe and alive in agreement with the detected levels of internalization in each cell line. In addition, the bimodal action of simultaneous chemo- and photothermal bioactivity provided by the platform largely enhances the therapeutic outcomes. Finally, it was observed that our PSS/DOXO/PLL/HA-coated AuNRs induced cell mortality mainly through apoptosis in HeLa cells even in the presence of NIR light irradiation, which agrees with the idea of the chemo-activity of DOXO predominating over the photothermal effect to induce cell death, favoring an apoptotic pathway over necrosis for cell death.

Indexed as

Hyperthermia, InducedNanotubesNeoplasmsDoxorubicinDrug Delivery SystemsGoldHeLa CellsHumansPhototherapyDoxorubicinGoldcell death pathwaygold nanorodslayer assemblymultimodal therapyphotothermal therapy

Identifiers

PMID36361892
PMCPMC9659131

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.